$611.57
Price
$17.1B
Market Cap
35.9
P/E Ratio
31.7
Forward P/E
$17.05
EPS (TTM)
—
Dividend Yield
$503M
Cash
$114M
Total Debt
28M
Shares Out
$373.00
$677.90
52-Week Range
Institutional Ownership of Medpace Hldgs Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 253.9K | $134M | $312.05 | +95.99% | ||
| 52.4K | $28M | $340.63 | +70.85% |
Trading Activity for Medpace Hldgs Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| SELL | -0.8% | 253.9K | $134M | $455.66 | |
| SELL | -16.4% | 52.4K | $28M | $455.66 | |
| 2026-Q1 | |||||
| SELL | -2.8% | 256.1K | $123M | $468.09 | |
| SELL | -24.1% | 62.7K | $30M | $468.09 | |
| 2025-Q4 | |||||
| BUY | +0.6% | 263.3K | $148M | $569.98 | |
| SELL | -35.3% | 82.6K | $46M | $569.98 | |
| 2025-Q3 | |||||
| BUY | +0.0% | 261.8K | $135M | $459.29 | |
| 2025-Q2 | |||||
| BUY | +3.9% | 261.8K | $82M | $299.99 | |
| 2025-Q1 | |||||
| BUY | +7.5% | 251.9K | $77M | $339.46 | |
| 2024-Q4 | |||||
| BUY | +3.2% | 234.3K | $78M | $340.63 | |
| BUY | NEW | 127.5K | $42M | $340.63 | |
| 2024-Q3 | |||||
| BUY | +20.7% | 227.1K | $76M | $381.88 | |
| 2024-Q2 | |||||
| BUY | +1.6% | 188.1K | $77M | $396.12 | |
| 2024-Q1 | |||||
| BUY | +17.5% | 185.2K | $75M | $384.14 | |
| 2023-Q4 | |||||
| BUY | NEW | 157.7K | $48M | $274.50 | |
Insider Trading for Medpace Hldgs Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.